冠状动脉支架市场：市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033）

美国是心绞痛 (AP) 和心肌梗塞 (MI) 发生率最高的国家之一。 然而，二手资讯显示心臟病的盛行率正在下降。 这种下降可能是由于改变生活方式和减少吸烟等预防措施所致。 在中东等地区，心臟病的盛行率正在增加。 全球心臟病的增加是由于糖尿病、高血压、肥胖和吸烟等危险因素和合併症造成的。 此外，由于许多合併症与年龄密切相关，因此老年人口的增加预计也会导致疾病盛行率上升。 整体而言，都市化导致吸烟率上升、缺乏身体活动和不健康的生活方式。 冠状动脉支架市场分为冠状动脉裸金属支架、冠状动脉药物洗脱支架、冠状动脉覆膜支架及冠状动脉生物可吸收支架。

本报告深入了解全球冠状动脉支架市场，提供竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。Masu。

目录

目前冠状动脉支架市场及竞争状况

• 对主要产业趋势的见解
• 2015 年至 2033 年按细分市场划分的冠状动脉支架市场总收入及市场前景
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 冠状动脉支架市场SWOT分析
• 冠状动脉支架市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Abstract

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Coronary Stents market for the year 2020 and beyond. US has some of the highest rates of AP and MI. However, according to secondary sources the prevalence of heart disease is decreasing. This decline may be due to preventative efforts such as lifestyle changes and reduction in smoking. In regions, such as the Middle East for example the prevalence of heart disease is increasing. The global increase in heart disease can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence. Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. The Coronary Stents Market is segmented into Coronary Bare Metal Stents, Coronary Drug Eluting Stents, Coronary Covered Stents, Coronary Bioabsorbable Stents.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Coronary Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Coronary Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Coronary Stents market.
• Competitive dynamics insights and trends provided Coronary Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, Vascular Concepts Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Coronary stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Coronary Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Coronary Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Coronary Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable